Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Innovative Mouthwash in School-Aged Children With Fixed Orthodontic Appliances

13. juli 2026 opdateret af: Plovdiv Medical University

Laboratory and Clinical Evaluation of an Innovative Mouthwash in School-Aged Children With Fixed Orthodontic Appliances

Fixed metal orthodontic appliances create additional plaque-retentive areas around brackets, archwires and ligatures, making mechanical plaque control more difficult in children and adolescents. Increased plaque accumulation may contribute to gingival inflammation, bleeding, halitosis and early enamel changes. Therefore, adjunctive preventive agents, including mouthwashes, may be clinically useful as part of a comprehensive oral hygiene program during fixed orthodontic treatment.

The aim of the study is to evaluate the clinical effectiveness and tolerability of a test mouthwash in children and adolescents with fixed orthodontic appliances by monitoring plaque accumulation, gingival inflammation, gingival bleeding and halitosis.

Studieoversigt

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

90

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

      • Plovdiv, Bulgarien, 4000
        • Department of Paediatric dentistry, Faculty of Dental Medicine, Medical University of Plovdiv
        • Kontakt:
        • Ledende efterforsker:
          • Zalamova

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  1. Participants aged 12 to 17 years.
  2. Presence of fixed metal orthodontic appliances placed at least 6 months before enrollment.
  3. Generalized plaque-induced gingivitis.
  4. Full Mouth Bleeding Score greater than 30%.
  5. Gingival Index greater than 0.95 according to Loe and Silness.
  6. Written informed consent obtained from a parent or legal guardian.
  7. Participant willingness to comply with the study protocol.

Exclusion Criteria:

  1. Refusal to participate or withdrawal of informed consent.
  2. Non-compliance with the intervention regimen or inability to attend follow-up visits.
  3. Development of an adverse reaction or condition requiring discontinuation.
  4. Antibiotic or antimicrobial therapy during follow-up if it may affect the study outcomes.
  5. Presence of concomitant systemic diseases.
  6. Current systemic medication intake that could influence oral health or inflammatory status.
  7. Use of systemic or local antimicrobial agents during the previous 3 months, including mouthwashes, gels, chewing gums or other local oral agents.
  8. Known allergy or hypersensitivity to any component of the tested mouthwash formulations.
  9. Use of removable orthodontic appliances only. Inability or unwillingness to follow the study instructions.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Test Mouthwash
Participants rinsed with 15 ml of the prototype chlorhexidine-free pediatric mouthwash for 30-60 seconds twice daily for 21 days as an adjunct to standard oral hygiene.
Participants rinsed with a 15 ml prototype chlorhexidine-free pediatric mouthwash for 30-60 s twice daily for 21 days as an adjunct to standard oral hygiene.
Andre navne:
  • Sample 1
Aktiv komparator: Chlorhexidine Mouthwash
Participants rinsed with a 15 ml chlorhexidine-containing mouthwash for 30-60 s twice daily for 21 days as an adjunct to standard oral hygiene.
Participants rinsed with a 15 ml chlorhexidine-containing mouthwash for 30-60 s twice daily for 21 days as an adjunct to standard oral hygiene.
Andre navne:
  • Positiv kontrol
  • Eludril classic®
Placebo komparator: Placebo Mouthwash Group
Participants rinsed with 15 ml of the placebo mouthwash for 30-60 seconds twice daily for 21 days as an adjunct to standard oral hygiene.
Participants rinsed with a 15 ml placebo mouthwash for 30-60 s twice daily for 21 days as an adjunct to standard oral hygiene.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Orthodontic Plaque Index (OPI)
Tidsramme: Baseline, day 7, day 21, and 3 months

The Orthodontic Plaque Index focuses on the areas around the bracket, which represents an additional plaque-retentive factor. The dentition is divided into sextants and plaque accumulation is scored from 0 to 4. The mesial, distal, incisal and cervical areas around each bracket are evaluated. The highest score among all sextants defines the oral hygiene level and identifies the need for preventive measures.

Registry field data

Code 0 No plaque accumulation is detected.

Code 1 Plaque accumulation is detected on one tooth surface around the bracket base.

Code 2 Plaque accumulation is detected on two tooth surfaces around the bracket base.

Code 3 Plaque accumulation is detected on three tooth surfaces around the bracket base; increased risk of caries and gingivitis is assumed.

Code 4 Plaque accumulation is detected on all tooth surfaces around the bracket base and/or gingival inflammation is present.

Baseline, day 7, day 21, and 3 months
Gingival Index (Loe & Silness)
Tidsramme: Baseline, day 7, day 21, and 3 months

The index evaluates color, contour and bleeding of the gingival tissues. A World Health Organization (WHO) 621 periodontal probe is used to examine the gingival sulcus, and bleeding is recorded within 10 seconds.

Code 0 Normal gingiva.

Code 1 Mild inflammation: slight color change and slight edema, without bleeding on probing.

Code 2 Moderate inflammation: redness, edema and glazing, with bleeding on probing.

Code 3 Severe inflammation: marked redness and edema, ulceration and tendency to spontaneous bleeding.

Baseline, day 7, day 21, and 3 months
Full Mouth Bleeding Score (FMBS)
Tidsramme: Baseline, day 7, day 21, and 3 months
FMBS assesses provoked bleeding from the gingival sulcus using a WHO 621 periodontal probe. Bleeding is recorded within 10 seconds and marked as present (+) or absent (-). The index is calculated as the percentage of gingival sites with provoked bleeding from all examined sites for each child.
Baseline, day 7, day 21, and 3 months
Full Mouth Plaque Score (FMPS)
Tidsramme: Baseline, day 7, day 21, and 3 months
Dental plaque accumulation was assessed using the Full Mouth Plaque Score. The presence of visible plaque was recorded on tooth surfaces, and the result was expressed as the percentage of plaque-positive sites. Lower percentages indicate improved plaque control.
Baseline, day 7, day 21, and 3 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Halitosis Assessment
Tidsramme: Baseline, day 7, day 21, and 3 months
Halitosis was assessed by gas chromatography using OralChroma™. Volatile sulfur compounds were measured, including hydrogen sulfide, methyl mercaptan and dimethyl sulfide.
Baseline, day 7, day 21, and 3 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Tanya Zalamova, Plovdiv Medical University

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. september 2026

Primær færdiggørelse (Anslået)

31. december 2026

Studieafslutning (Anslået)

31. maj 2028

Datoer for studieregistrering

Først indsendt

13. juli 2026

Først indsendt, der opfyldte QC-kriterier

13. juli 2026

Først opslået (Faktiske)

17. juli 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

17. juli 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

13. juli 2026

Sidst verificeret

1. juli 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 17/2024
  • 02/2024 (Anden identifikator: Medical University Plovdiv)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Halitosis

Kliniske forsøg med Test mouthwash

3
Abonner